Brief: Biomed-Lublin Says Conflict In Ukraine Might Have Negative Impact On Co's Future Results

Synthaverse SA

15/03/2022 07:45

March 15 (Reuters) - Biomed-Lublin Wytwórnia Surowic I
Szczepionek SA  BML.WA :
    * SAID ON MONDAY THAT ARMED CONFLICT IN UKRAINE MAY HAVE
NEGATIVE
IMPACT ON COMPANY'S EXPORT SALES TO UKRAINE AND BELARUS IN SHORT
TERM
    * COMPANY IS CLOSELY COOPERATING WITH ALPEN PHARMA AG, WHO
IS
RESPONSIBLE FOR SALE OF COMPANY'S PRODUCTS IN UKRAINE AND
BELARUS (COMPANY DOES NOT EXPORT ITS PRODUCTS TO RUSSIA)
    * MANAGEMENT BOARD BELIEVES THAT THERE IS RISK THAT ARMED
CONFLICT
IN UKRAINE, AS WELL AS POLITICAL AND ECONOMIC SITUATION IN
EASTERN EUROPE MAY HAVE IMPACT ON COMPANY FUTURE RESULTS
    * IN 2021 ANNUAL REVENUES FROM UKRAINIAN MARKET ACCOUNTED
FOR
APPROXIMATELY 10% OF TOTAL SALES REVENUE, WHILE ON BELARUSIAN
MARKET IT WAS 1.5%
    * IN COMPANY'S EVALUATION, ONGOING ARMED CONFLICT AND
RELATED
SANCTIONS MAY HAVE EFFECT ON THE EXTENSION OR EVEN TEMPORARY
INTERRUPTION Of DELIVERIES OF COMPANY'S PRODUCTS TO UKRAINE, IN
PARTICULAR DUE TO LOGISTICAL PROBLEMS
    * AT SAME TIME, DUE TO SIGNIFICANT INFLUX OF REFUGEES FROM
UKRAINE, COMPANY EXPECTS TO SEE INCREASE IN DEMAND FOR BCG
ANTI-TUBERCULOSIS VACCINE AND OTHER PRODUCTS BOTH ON DOMESTIC
MARKET AND IN CENTRAL AND EASTERN EUROPE, WHICH IS CONFIRMED BY
INCREASED INTEREST IN COMPANY'S MEDICINAL PRODUCTS
    * COMPANY HAS TAKEN APPROPRIATE STEPS TO SECURE PRODUCTION
POTENTIAL TO MEET ADDITIONAL DEMAND, WHICH MAY REACH FROM FEW TO
SEVERAL PERCENT OF DOMESTIC SALES 
    * THE COMPANY DOES NOT MARKET PRODUCTS THAT ARE MANUFACTURED
OR
IMPORTED FROM UKRAINE, RUSSIA OR BELARUS
    * THE COMPANY ALSO DOES NOT USE RAW MATERIALS AND MATERIALS
FOR
PRODUCTION FROM THE ABOVE-MENTIONED COUNTRIES, THEREFORE IT DOES
NOT CURRENTLY IDENTIFY THE RISK ON THE IMPACT OF ARMED CONFLICT
ON THE PRODUCTION PROCESS, AS WELL AS THE SALE OF ITS GOODS IN
POLAND AND OTHER COUNTRIES

    
    
 Source text for Eikon:  urn:newsml:reuters.com:*:nEMbXQckTa
 Further company coverage:  BML.WA  

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))